Dudediligence.

Biofrontera Inc

BFRINASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$9.0MSep ’24$12.6MDec ’24$8.6MMar ’25$9.0MJun ’25$7.0MSep ’25$17.1MDec ’25$10.1MMar ’26$12.0MJun ’26
Net income, by quarter
−$5.7MSep ’24−$1.4MDec ’24−$4.2MMar ’25−$5.3MJun ’25−$6.6MSep ’25$5.6MDec ’25−$4.8MMar ’26−$604,000Jun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$24.1M$28.7M$34.1M$37.3M$41.7M
Operating income−$25.2M−$18.6M−$22.7M−$17.2M−$11.3M
Net income−$37.7M−$640,000−$20.1M−$17.8M−$10.5M
Operating cash flow−$26.7M−$16.2M−$24.9M−$10.3M−$13.4M
Free cash flownone on file−$16.2M−$24.9M−$10.3M−$13.4M
Cash$24.5M$17.2M$1.3M$5.9M$6.4M
Debtnone on filenone on file$3.9Mnone on filenone on file
Shares outstanding17.1M1.3M1.5M8.9M11.6M